Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR
Fingerprint
Dive into the research topics where Amir Horowitz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires
Philippon, C., Tao, S., Clement, D., Haroun-Izquierdo, A., Kichula, K. M., Netskar, H., Brandt, L., Oei, V. S., Kanaya, M., Lanuza, P. M., Schaffer, M., Goodridge, J. P., Horowitz, A., Zhu, F., Hammer, Q., Sohlberg, E., Majhi, R. K., Kveberg, L., Önfelt, B., Norman, P. J., & 1 others, 16 Aug 2023, In: Blood advances. 7, 16, p. 4492-4504 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
Wei, C. H., Huang, L., Kreh, B., Liu, X., Tyutyunyk-Massey, L., Kawakami, M., Chen, Z., Shi, M., Kozlov, S., Chan, K. C., Andresson, T., Carrington, M., Vuligonda, V., Sanders, M. E., Horowitz, A., Hwu, P., Peng, W., Dmitrovsky, E. & Liu, X., Dec 2023, In: Scientific Reports. 13, 1, 14907.Research output: Contribution to journal › Article › peer-review
Open Access -
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III
Reike, M. J., Ingersoll, M. A., Müller, D. C., Zuiverloon, T. C. M., Strandgaard, T., Kamat, A. M., Williams, S. B., Seiler, R., Todenhöfer, T., Dyrskjøt, L., Nawroth, R., Goebell, P., Schmitz-Dräger, B., Sfakianos, J. P., Meeks, J., Horowitz, A. & Black, P. C., May 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 5, p. 211-218 8 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses
Lin, Z., Bashirova, A. A., Viard, M., Garner, L., Quastel, M., Beiersdorfer, M., Kasprzak, W. K., Akdag, M., Yuki, Y., Ojeda, P., Das, S., Andresson, T., Naranbhai, V., Horowitz, A., McMichael, A. J., Hoelzemer, A., Gillespie, G. M., Garcia-Beltran, W. F. & Carrington, M., Jul 2023, In: Nature Immunology. 24, 7, p. 1087-1097 11 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients
Bernson, E., Huhn, O., Karlsson, V., Hawkes, D., Lycke, M., Cazzetta, V., Mikulak, J., Hall, J., Piskorz, A. M., Portuesi, R., Vitobello, D., Fiamengo, B., Siesto, G., Horowitz, A., Ghadially, H., Mavilio, D., Brenton, J. D., Sundfeldt, K. & Colucci, F., Jul 2023, In: Cancers. 15, 13, 3362.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
Purple Biotech Ltd ADR (PPBT) Shares Down Despite Recent Market Volatility
26/10/23
1 item of Media coverage
Press/Media
-
Navigating the Volatility of Purple Biotech Ltd ADR’s (PPBT) Stock
17/10/23
1 item of Media coverage
Press/Media
-
Purple Biotech Ltd ADR (PPBT) vs. Its Peers: A Comparison
13/10/23
1 item of Media coverage
Press/Media
-
Purple Biotech Ltd. (PPBT) Shares Rise Despite Market Challenges
4/09/23
1 item of Media coverage
Press/Media